MLchartDataset catalogue

insulin sensitizer S-707106

Term · Oncology and biomedicine · MLC-T-ONC-014468

An orally available protein and insulin sensitizer with anti-hyperglycemic activity. Upon oral administration, S-707106 increases the sensitivity of target organs to insulin, through an as of yet not fully elucidated mechanism. This agent may lower blood glucose levels.

Table 1. Record
IdentifierMLC-T-ONC-014468
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-014468",
  "term": "insulin sensitizer S-707106",
  "field": "Oncology and biomedicine",
  "definition": "An orally available protein and insulin sensitizer with anti-hyperglycemic activity. Upon oral administration, S-707106 increases the sensitivity of target organs to insulin, through an as of yet not fully elucidated mechanism. This agent may lower blood glucose levels.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/insulin-sensitizer-s-707106/"
}

Record 9,308 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.